NASDAQ
04.03.25 | 22:00
0,095 US-Dollar
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.12. | Zomedica Corp.: Zomedica Announces Collaboration with Prime Video as Assisi Loop Products Appear in New Holiday Film Merv | 303 | ACCESS Newswire | The collaboration highlights Zomedica's commitment to expanding pet wellness education as Assisi Loop technology is featured in the highly anticipated movie Merv now available on Prime Video ANN ARBOR... ► Artikel lesen | |
| ZOMEDICA Aktie jetzt für 0€ handeln | |||||
| 04.12. | Zomedica Corp.: Zomedica Expands TRUFORMA Diagnostic Menu with Launch of Equine Progesterone Assay | 279 | ACCESS Newswire | Newest assay expands TRUFORMA market opportunity by building on endocrinology foundation to address reproductive health in the equine segment ANN ARBOR, MI / ACCESS Newswire / December 4, 2025 / Zomedica... ► Artikel lesen | |
| 24.11. | Zomedica steigert Umsatz um 16 %, verfehlt aber Gewinnprognose - Aktie legt dennoch kräftig zu | 6 | Investing.com Deutsch | ||
| 11.11. | Zomedica Corp.: Zomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review | 370 | ACCESS Newswire | November session to provide strategic context for Zomedica's product platforms featured in the previous Fourth Friday at Four Webinars ANN ARBOR, MI / ACCESS Newswire / November 11, 2025 / Zomedica... ► Artikel lesen | |
| 06.11. | Zomedica Corp.: Zomedica Achieves ISO 13485 Certification, Underscoring Strengthened Quality Infrastructure and Commercial Potential | 374 | ACCESS Newswire | Certification enhances global market readiness, reinforces quality systems, and supports Zomedica's long-term growth strategy ANN ARBOR, MI / ACCESS Newswire / November 6, 2025 / Zomedica Corp. (OTCQB:ZOMDF)... ► Artikel lesen | |
| 04.11. | Zomedica reports Q3 results | 4 | Seeking Alpha | ||
| 04.11. | Zomedica Corp.: Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth | 494 | ACCESS Newswire | Zomedica posts highest quarterly revenue ever and record year-over-year revenue for 19th straight quarter! ANN ARBOR, MI / ACCESS Newswire / November 4, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica"... ► Artikel lesen | |
| 04.11. | Zomedica Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 04.11. | Zomedica Corp. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 23.10. | Zomedica Corp.: Zomedica Announces Launch of the Assisi Loop Lounge, Scientifically Backed tPEMF Therapy for Pets | 708 | ACCESS Newswire | Combining peer-reviewed science, superior comfort, and thoughtful design, the Assisi Loop Lounge expands Zomedica's evidence-based therapeutic portfolio and reinforces Assisi's leadership in targeted... ► Artikel lesen | |
| 14.10. | Zomedica Corp.: Zomedica Expands Grovet's Distribution Agreement to Include Zomedica's Diagnostic and Therapeutic Device Products Across the European Union | 357 | ACCESS Newswire | Expanded agreement strengthens Zomedica's European presence, broadens product portfolio on the market, and positions the Company to capture growth in the multi-billion-dollar global veterinary diagnostics... ► Artikel lesen | |
| 09.10. | Zomedica Corp.: Zomedica to Spotlight VETGuardian Zero Touch Monitor in October "Fourth Friday at Four" Webinar | 272 | ACCESS Newswire | Live session on October 24th will showcase how the VETGuardian Monitor enhances patient care, improves workflow efficiency, and expands global market opportunities ANN ARBOR, MI / ACCESS Newswire /... ► Artikel lesen | |
| 23.09. | Zomedica Corp.: Zomedica Expands TRUFORMA Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate Assay | 370 | ACCESS Newswire | First and only in-clinic multiplexed Cobalamin & Folate assay now validated for feline patients ANN ARBOR, MI / ACCESS Newswire / September 23, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the... ► Artikel lesen | |
| 18.09. | Zomedica Corp.: Zomedica Expands TRUVIEW and TRUFORMA Intellectual Property Portfolio with Four Newly Issued U.S. Patents | 275 | ACCESS Newswire | Intellectual property portfolio now includes 228 Patents and 153 Trademarks providing robust protection for the Company's product platforms in the rapidly growing multi-billion dollar veterinary diagnostics... ► Artikel lesen | |
| 12.09. | Zomedica Corp.: Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUVIEW Digital Cytology Microscope - Transforming Veterinary Imaging | 389 | ACCESS Newswire | Cutting-Edge Digital Microscopy System Featured in Monthly Series Showcasing Innovation in Veterinary Care ANN ARBOR, MI / ACCESS Newswire / September 12, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica"... ► Artikel lesen | |
| 10.09. | Zomedica Corp.: Zomedica and UXR Announce Expanded Distribution Agreement in Canada | 443 | ACCESS Newswire | Agreement strengthens Canadian veterinarians' access to Zomedica's advanced therapeutic and monitoring solutions ANN ARBOR, MI / ACCESS Newswire / September 10, 2025 / Zomedica Corp. (OTCQB:ZOMDF),... ► Artikel lesen | |
| 03.09. | Zomedica Corp.: Zomedica Strengthens UK Market Position with Strategic Distribution Agreement for High-Growth Veterinary Innovation Portfolio | 359 | ACCESS Newswire | Strategic partnership with Pioneer Veterinary Products Limited expands Zomedica's presence in the UK veterinary market through distribution of its leading point-of-care solutions ANN ARBOR, MI / ACCESS... ► Artikel lesen | |
| 19.08. | Zomedica partners with VerticalVet for advanced veterinary tech | 4 | Seeking Alpha | ||
| 19.08. | Zomedica Corp.: Zomedica and VerticalVet Announce Strategic Partnership to Deliver Advanced Veterinary Technologies to Independent Practices | 387 | ACCESS Newswire | New agreement brings innovative shock wave, tPEMF therapy, monitoring, and bleeding control solutions to more than 2,200 member clinics nationwide ANN ARBOR, MI / ACCESS Newswire / August 19, 2025 /... ► Artikel lesen | |
| 12.08. | Zomedica Corp.: Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the VETIGEL Hemostatic Product - The Future of Rapid Bleeding Control in Veterinary Medicine | 348 | ACCESS Newswire | Revolutionary Plant-Based Technology Gains Momentum as a Game-Changer in Wound Management ANN ARBOR, MI / ACCESS Newswire / August 12, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company")... ► Artikel lesen |
1 2 Weiter >>
40 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 44,460 | -0,58 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat Siemens Healthineers mit "Outperform" und einem Kursziel von 52,90 Euro in die Bewertung wieder aufgenommen. Nach einem für die... ► Artikel lesen | |
| HEARTFLOW | 30,510 | +6,49 % | Hedge Fund and Insider Trading News: Ken Griffin, Warren Buffett, Israel Englander, Viking Global, Point72 Asset Management, Heartflow Inc (HTFL), Teva Pharmaceutical Industries Ltd (TEVA), and More | ||
| PROGYNY | 26,630 | +1,80 % | Progyny, Inc. - 8-K, Current Report | ||
| FRESENIUS | 48,300 | +0,79 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius mit einem Kursziel von 53,60 Euro auf "Overweight" belassen. Die Veranstaltung mit dem Biopharma-Management der Bad... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,340 | +0,15 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,640 | -1,25 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| ADAPTHEALTH | 9,970 | -2,54 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| GERRESHEIMER | 26,960 | -0,15 % | Gerresheimer-Aktie: Ist das der Beginn eines großen Comebacks? | Erst vor drei Wochen sackte der Kurs der Gerresheimer-Aktie auf ein 15-Jahrestief bei 23,50 € ab. Wer so klug war, zu diesem Zeitpunkt in den Spezialverpackungshersteller zu investieren, darf sich bis... ► Artikel lesen | |
| OTTOBOCK | 64,95 | -4,27 % | XETR MODIFICATIONS OF SHARE INDICES EFFECTIVE 22 DECEMBER 2025 | For the following instruments, the Product Assignment Group in Xetra (MIC: XETR) will change with effect from 22 December 2025:Instrument Mnemonic ISIN Product Assignment Group (old) Product Assignment... ► Artikel lesen | |
| CASTLE BIOSCIENCES | 39,440 | -0,40 % | Castle Biosciences, Inc.: Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| BRIGHTSPRING HEALTH SERVICES | 37,490 | +2,32 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| TALKSPACE | 3,550 | -1,39 % | Talkspace Releases Family Guide on Why Stress Spikes in December, and How to Break the Cycle | ||
| CARL ZEISS MEDITEC | 40,080 | +0,91 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 35,10 Euro auf "Underweight" belassen. Quartalsbericht und Ausblick der Jenaer hätten... ► Artikel lesen | |
| RXSIGHT | 12,030 | -2,27 % | RxSight, Inc. - 8-K, Current Report | ||
| ALIGNMENT HEALTHCARE | 20,420 | +0,05 % | Managed care stocks diverge in 2025: ALHC and OSCR rise while UNH, CNC slide |
ZOMEDICA CORP gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,095 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZOMEDICA CORP finden Sie auf Wallstreet Online.